Background illustration for clinical trials search

Oncology Clinical Trials

Browse 9,171 oncology clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

for
Breast Cancer, Breast-conserving Surgery,
Location: Galveston TX
Sponsor: Innoblative Designs, Inc.

Sex: Female

Age: 50+

Code: NCT07206121

Recruiting
Active & Responsive

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

for
Colon and Rectal Cancer
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT07433673

Phase2, Recruiting
Active & Responsive

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

for
Lymphedema, Breast Cancer
Location: Boston MA, Montreal, St Louis MO, Vancouver
Sponsor: University Hospital, Basel, Switzerland

Sex: All

Age: 18+

Code: NCT05890677

Recruiting
Active & Responsive

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

for
Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm,
Location: Ann Arbor MI, Duarte CA, Los Angeles CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 4 - 25

Code: NCT04510051

Phase1, Recruiting
Active & Responsive

CREATE: Art for Children With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 8 - 13

Code: NCT06342453

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

for
Breast Cancer
Location: Boston MA, Summit NJ
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05950945

Phase3, Recruiting
Active & Responsive

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

for
Solid Tumor
Location: Dallas TX, Scottsdale AZ, Portland OR, El Segundo CA,
Sponsor: Alyssum Therapeutics

Sex: All

Age: 18+

Code: NCT06234098

Phase1, Phase2, Recruiting
Active & Responsive

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

for
Cutaneous Squamous Cell Carcinoma,
Location: Pittsburgh PA
Sponsor: Falo, Louis, MD

Sex: All

Age: 18+

Code: NCT05377905

Phase1, Phase2, Recruiting
Active & Responsive

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06320405

Phase1, Phase2, Recruiting
Active & Responsive

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for
Advanced Solid Tumors
Location: Moncton, Hackensack NJ, Fairfax VA, Kingston, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05067283

Phase1, Recruiting
Active & Responsive

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 12+

Code: NCT05533697

Phase1, Phase2, Recruiting
Active & Responsive

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

for
Bone Pain, Metastatic Malignant Neoplasm in the Bone,
Location: Boston MA, New York NY, Philadelphia PA, Atlanta GA,
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT03858205

Recruiting
Active & Responsive

Pancreas Registry and High Risk Registry

for
Pancreas Cancer, Pancreatitis, Chronic Pancreatitis,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT02775461

Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Phase2, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: New York NY, Albany NY, Doylestown PA, Brandywine MD,
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase2, Recruiting
Active & Responsive

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

for
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer,
Location: New York NY
Sponsor: Deborah Doroshow

Sex: All

Age: 18+

Code: NCT04997993

Phase1, Recruiting
Active & Responsive

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

for
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma,
Location: Cleveland OH, Columbus OH
Sponsor: Yuanquan Yang

Sex: All

Age: 18+

Code: NCT06263153

Phase2, Recruiting
Active & Responsive

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer

for
Cancer Related Cognitive Decline, Non-metastatic Breast Cancer
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05256745

Phase1, Phase2, Recruiting
Active & Responsive

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: New York NY, Hampton VA, Baltimore MD, Fairfax VA,
Sponsor: Proton Collaborative Group

Sex: Female

Age: 50+

Code: NCT01766297

Phase2, Recruiting
Active & Responsive

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

for
Locally Advanced Pancreatic Cancer
Location: Manhasset NY, Greenville NC, Washington D.C. DC,
Sponsor: RenovoRx

Sex: All

Age: 18+

Code: NCT03257033

Phase3, Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer